Novavax Analyst Says COVID-19 Vaccine Could Net $400M In Yearly Sales By: TalkMarkets June 29, 2020 at 15:50 PM EDT Novavax, Inc. shares are on a dream run this year amid catalysts including its COVID-19 vaccine program. Read More >> Related Stocks: Novavax Inc